Lungs News and Research

RSS

MUSC researchers receive $1.68 million NIH grant to study better treatment for chronic pancreatitis, diabetes

MUSC researchers received a $1.68 million National Institutes of Health grant to explore a better treatment for chronic pancreatitis, with the hopes that it also may shed light on a future cure for patients with type 1 diabetes.

4 Jan 2016

HealthWell Foundation opens new fund to provide financial assistance to Medicare patients suffering from RCC

The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, today announced it has opened a new fund to provide financial assistance to Medicare patients suffering from renal cell carcinoma (RCC).

31 Dec 2015

SDSU researchers explore ways to eradicate thirdhand smoke

When cigarette smoke is blown into the environment, its chemical constituents don't just vanish into thin air. Residue from the smoke settles into, accumulates and is stored in the surrounding environment, such as upholstery, carpets, walls, clothing and curtains.

30 Dec 2015

Discovery Laboratories initiates AEROSURF phase 2b clinical trial in premature infants with RDS

Discovery Laboratories, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated its AEROSURF phase 2b clinical trial in premature infants 26 to 32 weeks gestational age (GA) receiving non-invasive nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS).

29 Dec 2015

E-cigarettes damage cells in ways that could lead to cancer

Adding to growing evidence on the possible health risks of electronic cigarettes, a lab team at the Veterans Affairs San Diego Healthcare System tested two products and found they damaged cells in ways that could lead to cancer. The damage occurred even with nicotine-free versions of the products.

29 Dec 2015

FDA approves non-alcoholic Docetaxel Injection

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

29 Dec 2015

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Nearly 300,000 soldiers have returned from service in Iraq and Afghanistan with symptoms of traumatic brain injuries due to blast shockwaves. Such injuries often go untreated because they are undetected by brain scans despite the symptoms' presence.

24 Dec 2015

Personalized respiratory-motion system enables more precise lung cancer imaging

Lung cancer patients know that precise medical imaging can help a surgeon eradicate tumors and preserve healthy tissue.

24 Dec 2015

Selexipag holds promise for treatment of pulmonary hypertension

Living with pulmonary arterial hypertension is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data to be published in the Dec. 24 issue of the New England Journal of Medicine.

24 Dec 2015

Lower levels of antibodies in saliva linked to increased risk of mortality

New research from the University of Birmingham has found that lower levels of antibodies in saliva are associated with of an elevated risk of mortality, and could be an early indicator of risk.

24 Dec 2015

Working Group identifies many potential genetic contributors to weight loss

In the midst of the holiday season, celebratory get-togethers can mean overindulging on treats and high-calorie foods, leaving many of us struggling to keep off the extra pounds. With as many as two-thirds of American adults already carrying excess weight, and one third with obesity, maintaining weight can be the biggest challenge, say researchers.

24 Dec 2015

IASLC lauds FDA approval of alectinib for lung cancer treatment

The International Association for the Study of Lung Cancer (IASLC) is once again gratified to see the approval of a new second-generation lung cancer treatment that can help many patients in their battle against the disease.

24 Dec 2015

New biopsy system shows promise for early detection of colorectal cancer

A university spin-off, AWSensors, is coordinating the European project LIQBIOPSENS to develop liquid biopsy technologies for the early detection of colorectal cancer.

23 Dec 2015

ONR-sponsored study explores cause of extreme fatigue in Navy divers

To determine the cause of extreme fatigue in Navy divers after routine missions, the Office of Naval Research (ONR) is sponsoring work examining the most critical weapon in a diver's arsenal--oxygen itself.

23 Dec 2015

Shells of plant virus trigger immune system to wipe out tumors, provide protection against metastases

The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.

23 Dec 2015

Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

A national study involving 53,000 patients and 11 institutions (including Wake Forest Baptist) compared CT screens with chest X-rays and found that the scanning reduced lung cancer mortality by 20 percent in this high-risk population.

23 Dec 2015

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an investigational therapy in patients with previously treated EGFR mutant-positive non-small cell lung cancer.

23 Dec 2015

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

22 Dec 2015

Researchers reveal inherited genetic errors across 12 cancer types

Researchers long have known that some portion of the risk of developing cancer is hereditary and that inherited genetic errors are very important in some tumors but much less so in others.

22 Dec 2015

Study shows more patients with advanced NSCLC may benefit from pembrolizumab

More patients with advanced non-small-cell lung cancer (NSCLC) could benefit from pembrolizumab, says Professor Roy Herbst, Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven, presenting promising results from the pivotal phase 2/3 KEYNOTE-010 trial at the first ESMO Asia Congress in Singapore), in conjunction with a publication in The Lancet.

22 Dec 2015

Lungs News and Research

MUSC researchers receive $1.68 million NIH grant to study better treatment for chronic pancreatitis, diabetes

HealthWell Foundation opens new fund to provide financial assistance to Medicare patients suffering from RCC

SDSU researchers explore ways to eradicate thirdhand smoke

Discovery Laboratories initiates AEROSURF phase 2b clinical trial in premature infants with RDS

E-cigarettes damage cells in ways that could lead to cancer

FDA approves non-alcoholic Docetaxel Injection

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Personalized respiratory-motion system enables more precise lung cancer imaging

Selexipag holds promise for treatment of pulmonary hypertension

Lower levels of antibodies in saliva linked to increased risk of mortality

Working Group identifies many potential genetic contributors to weight loss

IASLC lauds FDA approval of alectinib for lung cancer treatment

New biopsy system shows promise for early detection of colorectal cancer

ONR-sponsored study explores cause of extreme fatigue in Navy divers

Shells of plant virus trigger immune system to wipe out tumors, provide protection against metastases

Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

Researchers reveal inherited genetic errors across 12 cancer types

Study shows more patients with advanced NSCLC may benefit from pembrolizumab

The ultimate guide to lung research tools and protocols eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News